Cannapharmarx CPMD
OTC CPMD
$0.00 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Cannapharmarx, Inc. (CPMD) Research & Development (2014 - 2015)

Updated

Cannapharmarx's Research & Development came in at $145,821 for Q3 2015, up 7.9% from $135,120 a year earlier but down 9.8% from the prior quarter.

Analysis

Cannapharmarx, Inc. (CPMD) Research & Development (2014 - 2015) Analysis & Trends

Over the trailing twelve months to Sep 30, 2015, Cannapharmarx reported Research & Development of $620,212; for FY2014, it came in at $324,149.

  • The five-year range for quarterly Research & Development is $37,201 (Q2 2014) to $161,721 (Q2 2015).
  • Business Quant data shows CPMD's Research & Development at $161,721 (Q2 2015), $160,842 (Q1 2015) and $151,828 (Q4 2014) in the three quarters before Q3 2015.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 145,821.00
Jun 30, 2015 161,721.00
Mar 31, 2015 160,842.00
Dec 31, 2014 151,828.00
Sep 30, 2014 135,120.00
Jun 30, 2014 37,201.00
API Access

Cannapharmarx, Inc. Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CPMD&period=max&api_key=YOUR_API_KEY